EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Original article. Cost-effectiveness of annual microalbuminuria screening in Thai diabetics

Attasit Srisubat, Jiruth Sriratanaban, Sureerat Ngamkiatphaisan, Kriang Tungsanga

Asian Biomedicine · 01.06.2014 · 8 (3) · 371-379

DOI: 10.5372/1905-7415.0803.301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Biomedicine, online erschienen am 04.02.2017. Verfasst von Attasit Srisubat und 3 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes is a leading cause of end stage renal disease (ESRD), which impacts on treatment costs and patients’ quality of life. Microalbuminuria screening in patients with diabetes as an early intervention is beneficial in slowing the progression of diabetic nephropathy.

Objectives

We aimed to assess the cost-effectiveness of annual microalbuminuria screening in type 2 diabetic patients.

Methods

We compared screening by urine dipsticks with a “do nothing” scenario. To replicate the natural history of diabetic nephropathy, a Markov model based on a simulated cohort of 10,000 45-year-old normotensive diabetic patients was utilized. We calculated the cost and quality of life gathered from a cross-sectional survey. The costs of dialysis were derived from The National Health Security Office (NHSO). We also calculated the incremental cost-effectiveness ratio (ICER) for lifetime with a future discount rate of 3%.

Results

The ICER was 3,035 THB per quality-adjusted life year (QALY) gained. One-way and probabilistic sensitivity analyses showed that all ICERs were less than the Thai Gross Domestic Product (GDP) per capita (150,000 THB in 2011) based on World Health Organization’s suggested criteria.

Conclusions

Annual microalbuminuria screening using urine dipsticks in type 2 diabetic patients is very costeffective in Thailand based on World Health Organization’s recommendations. This finding has corroborated the benefit of this screening in the public health benefit package.

Zitieren

APA

Srisubat, A., Sriratanaban, J., Ngamkiatphaisan, S., & Tungsanga, K. (2014). Original article. Cost-effectiveness of annual microalbuminuria screening in Thai diabetics. Asian Biomedicine, 8(3), 371-379. https://doi.org/10.5372/1905-7415.0803.301

Vancouver

Srisubat A, Sriratanaban J, Ngamkiatphaisan S, Tungsanga K. Original article. Cost-effectiveness of annual microalbuminuria screening in Thai diabetics. Asian Biomedicine. 2014;8(3):371-379. doi:10.5372/1905-7415.0803.301

BibTeX
@article{Srisubat2014,
  author = {Srisubat, Attasit and Sriratanaban, Jiruth and Ngamkiatphaisan, Sureerat and Tungsanga, Kriang},
  title = {Original article. Cost-effectiveness of annual microalbuminuria screening in Thai diabetics},
  journal = {Asian Biomedicine},
  year = {2014},
  volume = {8},
  number = {3},
  pages = {371--379},
  doi = {10.5372/1905-7415.0803.301}
}
Kostenlos starten →